Vietnam and France cooperate in transferring vaccine production technology

On May 26, Vietnam Vaccine Company (VNVC) and Sanofi Pharmaceutical Group (France) exchanged a cooperation agreement on transferring Sanofi's vaccine production technology at the VNVC Vaccine and Biological Products Factory.

The event marks an important step forward in the efforts of both sides to enhance cooperation in essential areas of the globalization era, especially in health and healthcare. This is also an important step for the Vietnamese health sector to expand international cooperation in advanced science and technology, proactively step by step to strengthen national health security, enhance the capacity to respond to future epidemic challenges, create a solid foundation for outstanding development in the biomedical field, bringing practical benefits to the people.

On the morning of May 26, 2025, after talks at the Presidential Palace,President Luong Cuong and French President Emmanuel Macron witnessed leaders of ministries, sectors and enterprises of the two countries exchanging bilateral cooperation documents. In the photo: Mr. Ngo Chi Dung, General Director and Chairman of the Board of Directors of Vietnam Vaccine Company and Ms. Zainab Sadat Qayyum, President of Sanofi Southeast Asia - India, exchanged documents on cooperation agreement on transferring vaccine production technology of Sanofi at VNVC Vaccine and Biological Products Factory. Photo: VNVC

According to the cooperation agreement, VNVC and Sanofi will gradually implement technology transfer to produce some important types of Sanofi vaccines used in large quantities in Vietnam. In addition, Sanofi will also accompany VNVC in training human resources and quality management in vaccine research and production.

Speaking about the significance of this cooperation, Mr. Ngo Chi Dung, General Director and Chairman of the Board of Directors of Vietnam Vaccine Company, emphasized that in the context that the Party and the State are creating the most favorable conditions for the development of the private economy , especially in the field of international cooperation in science and technology, the cooperation in technology transfer with Sanofi (France) is an important cooperation, helping VNVC in particular, and the Vietnamese vaccine manufacturing industry in general, to quickly improve production capacity to produce "made in Vietnam" vaccines of high quality comparable to the world.

In addition, technology transfer allows Vietnam to quickly access leading modern technologies, optimize research and development activities, promptly serve domestic needs and firmly ensure national health security.

Vaccines produced in Vietnam will help ensure adequate supply of high-quality vaccines and reduce vaccine costs for people.

According to Mr. Ngo Chi Dung, Sanofi is currently providing tens of millions of doses of high-quality vaccines to serve the needs of vaccination services in Vietnam such as: 6 in 1 Hexaxim, 4 in 1 Tetraxim, 3 in 1 diphtheria and tetanus prevention Adacel, Japanese encephalitis Imojev, rabies Verorab, meningitis caused by meningococcus Menactra, hepatitis A Avaxim, quadrivalent influenza Vaxigrip Tetra, typhoid Typhim VI.

It is expected that when these vaccines are produced in Vietnam, there will be an abundant supply and reduced costs, providing the opportunity for full vaccination and protecting the health of many children and adults.

"Access to the world's leading vaccine production technology from Sanofi, a pharmaceutical group with more than 100 years of experience and global influence, will allow Vietnam to proactively produce hundreds of millions of doses of high-quality vaccines each year to meet domestic demand and move towards export. Proactive domestic production will help ensure adequate supply of high-quality vaccines and reduce vaccine costs for people, which is of great significance in the vaccine coverage strategy, protecting the health of all people, thereby reducing the burden of disease, reducing medical examination and treatment costs, and improving the quality of life," Mr. Ngo Chi Dung added.

In its strategic vision of contributing to the goal of national vaccine self-sufficiency, VNVC is implementing the construction of a modern VNVC Vaccine and Biological Factory, with a scale of up to 26,000 m2 in Long An province with an initial investment of VND 2,000 billion. The factory is designed to meet the highest standards of modern Good Manufacturing Practice (GMP) of the World Health Organization (WHO), the European Union (EU) and the US Food and Drug Administration (FDA).

According to VNA

Source: https://doanhnghiepvn.vn/tin-tuc/viet-nam-va-phap-hop-tac-chuyen-giao-cong-nghe-san-xuat-vaccine/20250527061522016